Dr. Falk Pharma, in cooperation with its fully-owned subsidiary Losan Pharma GmbH, a leading contract development and manufacturing organisation (CDMO) partner and formulation expert, will develop an ...

Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a European distributor.

Strong performance and sales acceleration with total net sales of CHF 58 million in H1 2025 and increase of 145% compared to the same period in 2024, largely driven by sales in Europe. NDA approval ...

Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the pricing of its upsized initial public offering of 4,000,000 shares of its ...

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Epiq  announced today a first-of-its-kind agentic AI platform for the legal industry combining proprietary Epiq technology, best-in-class third-party ...

THEON announces formation of Theon Belgium subsidiary and establishment of new facilities in Belgium. Minority stake acquisition in Andres Industries to expand European presence and enhance ...

Black Jack 100 claimed victory in the 51st Rolex Fastnet Race in a breathtaking finale. The maxi monohull owned by Remon Vos, member of the Yacht Club de Monaco, crossed the finish line in Cherbourg ...

Daniel Hughes, Senior Vice President of North American Business at QPR Software, has chosen to pursue new opportunities outside the company and will be leaving his position effective immediately.

Hitachi Energy, a global leader in electrification, today announces a new deal worth up to $700 million USD with E.ON to deliver transformers across the German energy grid to bolster energy security, ...

The Arrangement Resolution required the approval of at least two-thirds of the votes cast at the Meeting in person or by proxy by Mandalay Shareholders. The voting results from the Meeting are as ...

MARLTON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced two major ...

Re-Vana Therapeutics Ltd, founded in 2016 as a spin-out from Queen’s University Belfast, is an ocular therapeutics and innovative ocular drug delivery company based in Belfast, Northern Ireland, and a ...